# Molecular Biophysics - Lecture 12

???+ note "Content Info"
 
    **Lecture**: #12   
    **Author**: Prof. Erik Lindahl  
    **Duration**: ~ 1 hour 41 minutes   
    **Date**: Feb 2021  
    **Youtube playlist**: [link](https://www.youtube.com/watch?v=h7Y9DYwvDcQ&list=PLuIpgNT2hMwTFQRSc--blleG3Hws57Azc)  
    **Videos**: 30  

    Courtesy of Prof. Erik Lindahl. Used with permission

## 1 - Discover drugs by targeting proteins (3:10)

<iframe width="750" height="315" src="https://www.youtube.com/embed/h7Y9DYwvDcQ" frameborder="0" allowfullscreen></iframe>

## 2 - Understand your drug target - SARS-CoV-2 as an example (7:19)

<iframe width="750" height="315" src="https://www.youtube.com/embed/Lp09g5HMS1g" frameborder="0" allowfullscreen></iframe>

## 3 - From biology to target proteins to binding sites (2:03)

<iframe width="750" height="315" src="https://www.youtube.com/embed/QqSNSa5SDWY" frameborder="0" allowfullscreen></iframe>

## 4 - Ligand bind into pockets of receptors (1:46)

<iframe width="750" height="315" src="https://www.youtube.com/embed/DzNL0HKZWrY" frameborder="0" allowfullscreen></iframe>

## 5 - Membrane proteins are some of the most common drug targets (1:25)

<iframe width="750" height="315" src="https://www.youtube.com/embed/zcmGpYqWP70" frameborder="0" allowfullscreen></iframe>

## 6 - Affinity vs. efficacy & agonists vs. antagonists vs. inverse agonists (6:08)

<iframe width="750" height="315" src="https://www.youtube.com/embed/Rcc25WrwG1c" frameborder="0" allowfullscreen></iframe>

## 7 - ADME / Tox (6:12)

<iframe width="750" height="315" src="https://www.youtube.com/embed/Ba96w0O5VKs" frameborder="0" allowfullscreen></iframe>

## 8 - Lipinski's rule(s) of 5 (7:22)

<iframe width="750" height="315" src="https://www.youtube.com/embed/ulPPr0knauc" frameborder="0" allowfullscreen></iframe>

## 9 - Fantastic drugs and where to find them (3:06)

<iframe width="750" height="315" src="https://www.youtube.com/embed/6sOSlRt3ycM" frameborder="0" allowfullscreen></iframe>

## 10 - Steps in the drug discovery process (6:04)

<iframe width="750" height="315" src="https://www.youtube.com/embed/PTsyOM6QahU" frameborder="0" allowfullscreen></iframe>

## 11 - From preclinical through phase I, II, & III trials to regulatory approval (6:37)

<iframe width="750" height="315" src="https://www.youtube.com/embed/tCxzDniyyxQ" frameborder="0" allowfullscreen></iframe>

## 12 - The omeprazole drug was carefully optimised and made billions for Astra (2:09)

<iframe width="750" height="315" src="https://www.youtube.com/embed/J7kebhv9q1w" frameborder="0" allowfullscreen></iframe>

## 13 - Hit identification (3:26)

<iframe width="750" height="315" src="https://www.youtube.com/embed/CBN2niuGQGo" frameborder="0" allowfullscreen></iframe>

## 14 - Experimental high-throughput screening to test 500,000 molecules (3:34)

<iframe width="750" height="315" src="https://www.youtube.com/embed/K9p_oaxjulE" frameborder="0" allowfullscreen></iframe>

## 15 - Quantitative structure-activity relationship (QSAR) tries to predict drugs (4:29)

<iframe width="750" height="315" src="https://www.youtube.com/embed/dOi8KwcecoM" frameborder="0" allowfullscreen></iframe>
       
## 16 - A pharmacophore is a profile of a drug's average properties (1:53)

<iframe width="750" height="315" src="https://www.youtube.com/embed/e27ycBwv-RI" frameborder="0" allowfullscreen></iframe>

## 17 - An example pharmacophore (2:38)

<iframe width="750" height="315" src="https://www.youtube.com/embed/ME9yr2qCYwc" frameborder="0" allowfullscreen></iframe>

## 18 - Docking is virtual (computational) high-throughput screening (4:03)

<iframe width="750" height="315" src="https://www.youtube.com/embed/FPIggXA72NU" frameborder="0" allowfullscreen></iframe>

## 19 - Docking methods - find best ways to put two molecules together (3:35)

<iframe width="750" height="315" src="https://www.youtube.com/embed/m7Q23R_Cbbc" frameborder="0" allowfullscreen></iframe>

## 20 - Docking has limited accuracy, but achieves extreme throughput (5:32)

<iframe width="750" height="315" src="https://www.youtube.com/embed/1WQDNoujnWs" frameborder="0" allowfullscreen></iframe>

## 21 - Fragment-based drug design tries to build a drug into a pocket (1:45)

<iframe width="750" height="315" src="https://www.youtube.com/embed/4caQ5bQGwfM" frameborder="0" allowfullscreen></iframe>

## 22 - Docking scoring functions can be physical, empirical, or knowledge-based (3:29)

<iframe width="750" height="315" src="https://www.youtube.com/embed/7mcBQPsgB98" frameborder="0" allowfullscreen></iframe>

## 23 - Knowledge-based (statistical) scoring on a grid is very fast (0:43)

<iframe width="750" height="315" src="https://www.youtube.com/embed/IYctCmtIKzc" frameborder="0" allowfullscreen></iframe>

## 24 - Allowing ligand flexibility and producing a final ranked list (1:48)

<iframe width="750" height="315" src="https://www.youtube.com/embed/femLNxnpc-0" frameborder="0" allowfullscreen></iframe>

## 25 - Experimental vs. virtual (docking) high-throughput screening (1:26)

<iframe width="750" height="315" src="https://www.youtube.com/embed/cJchATPyeM4" frameborder="0" allowfullscreen></iframe>

## 26 - Docking quality depends on the input structure or homology model quality (2:50)

<iframe width="750" height="315" src="https://www.youtube.com/embed/sC-9U_oxDt0" frameborder="0" allowfullscreen></iframe>

## 27 - Validation with experimental co-crystal structure determination (2:17)

<iframe width="750" height="315" src="https://www.youtube.com/embed/ugGJ3Sjs8Tc" frameborder="0" allowfullscreen></iframe>

## 28 - Improving affinity - lead optimization (2:35)

<iframe width="750" height="315" src="https://www.youtube.com/embed/AGIdtV49IrA" frameborder="0" allowfullscreen></iframe>

## 29 - Lead optimization for the HIV-1 protease inhibitor (3:16)

<iframe width="750" height="315" src="https://www.youtube.com/embed/uYTBjsg6GKc" frameborder="0" allowfullscreen></iframe>

## Study questions (0:47)

<iframe width="750" height="315" src="https://www.youtube.com/embed/dr6i9RiDZFo" frameborder="0" allowfullscreen></iframe>